FastWave Raises Funds to Accelerate Development of IVL Systems to Treat Cardiovascular Calcium

December 16, 2024—FastWave Medical, a clinical-stage medical device company, announced the close of a $19 million funding round earlier this year, increasing the total capital invested into the company to over $40 million.

According to the company, the funds will fuel FastWave’s development momentum and provide support for ongoing regulatory and clinical initiatives for its portfolio of intravascular lithotripsy (IVL) platforms to treat artery calcification. The company stated it is developing highly deliverable IVL catheters that offer durable, 360º sonic output.

The investment was led by Epic Venture Partners with participation from M&L Healthcare Investments and the company’s existing investors.

Arthur Lee, MD, and Steven Kum, MD, discussed the financing in FastWave’s press release. Dr. Lee, an interventional cardiologist, is Managing Partner of Epic Venture Partners. Dr. Kum, a vascular surgeon, is Chief Medical Officer of M&L Healthcare Investments.

“FastWave is moving quickly and decisively to become best-in-class in the IVL space,” commented Dr. Lee. “We are excited to support the FastWave team, as they continue to take down milestone after milestone in their mission to save lives and offer this groundbreaking technology to all who need it.”

Dr. Kum added, “FastWave Medical has all the hallmarks of a company poised for significant growth and impact. Their commitment to evidence-based development aligns perfectly with our investment philosophy, and we’re excited to be a part of a new era of IVL innovation that addresses the gaps left by current technologies.”